Bolt Biotherapeutics (BOLT) Revenue & Revenue Breakdown
Bolt Biotherapeutics Revenue Highlights
Latest Revenue (Y)
$7.69M
Latest Revenue (Q)
$1.22M
Bolt Biotherapeutics Revenue by Period
Bolt Biotherapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $7.69M | -2.36% |
| 2023-12-31 | $7.88M | 37.48% |
| 2022-12-31 | $5.73M | 354.68% |
| 2021-12-31 | $1.26M | 445.45% |
| 2020-12-31 | $231.00K | 7.44% |
| 2019-12-31 | $215.00K | 100.00% |
| 2018-12-31 | - | - |
Bolt Biotherapeutics generated $7.69M in revenue during NA 2024, up -2.36% compared to the previous quarter, and up 3576.74% compared to the same period a year ago.
Bolt Biotherapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $1.22M | 100.00% |
| 2024-12-31 | - | -100.00% |
| 2024-09-30 | $1.14M | -10.51% |
| 2024-06-30 | $1.27M | -75.82% |
| 2024-03-31 | $5.27M | 152.47% |
| 2023-12-31 | $2.09M | -17.37% |
| 2023-09-30 | $2.53M | 76.41% |
| 2023-06-30 | $1.43M | -21.52% |
| 2023-03-31 | $1.83M | 29.41% |
| 2022-12-31 | $1.41M | -33.19% |
| 2022-09-30 | $2.11M | 51.62% |
| 2022-06-30 | $1.39M | 71.34% |
| 2022-03-31 | $813.00K | 60.04% |
| 2021-12-31 | $508.00K | -32.45% |
| 2021-09-30 | $752.00K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | -100.00% |
| 2020-06-30 | $67.00K | -59.15% |
| 2020-03-31 | $164.00K | 152.31% |
| 2019-12-31 | $65.00K | -46.28% |
| 2019-09-30 | $121.00K | 734.48% |
| 2019-06-30 | $14.50K | - |
| 2019-03-31 | $14.50K | - |
Bolt Biotherapeutics generated $1.22M in revenue during Q1 2025, up 100.00% compared to the previous quarter, and up 58.50% compared to the same period a year ago.